Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mukhtyar C et al. – A review summarizes data available for the effect of primary systemic vasculitis on cardiovascular endpoints (coronary artery disease, congestive cardiac failure, hypertension, aortic aneurysm) in all age groups. A discussion is presented of the interplay between activated endothelium, autoimmune mechanisms and treatment factors to produce a direct insult or increased atherogenic potential of primary systemic vasculitis. Recommendations for cardiovascular endpoints are offered.

Related Articles

European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis
Current Opinion in Rheumatology, 10/16/09    Relevance Score: 92%

Resolution of anti-neutrophil cytoplasmic antibody-associated vasculitis after resection of gastric cancer
Modern Rheumatology, 10/19/09    Relevance Score: 91%

Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9
Journal of Rheumatology, 10/20/09    Relevance Score: 89%

Cutaneous vasculitis induced by TNF inhibitors: a report of three cases
Modern Rheumatology, 10/16/09    Relevance Score: 88%

Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis
Clinical and Experimental Nephrology, 10/09/09    Relevance Score: 88%

Today in Vascular Medicine...keeping you current

Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
Circulation, 12/15/09

Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09

Update on perioperative bridging in patients on chronic oral anticoagulation
Expert Review of Cardiovascular Therapy , 12/15/09